(May 11, 2023 at 6:55 pm)brewer Wrote: The Food and Drug Administration’s (FDA) Nonprescription Drugs Advisory Committee and the Obstetrics, Reproductive, and Urologic Drugs Advisory Committee voted 17 to 0, with no abstentions, that the benefits of making Opill®, a progestin-only daily oral birth control pill, available for over-the-counter (OTC) use outweighs the risks.
https://www.empr.com/home/news/fda-panel...SubId=&NID=
Recent history has amply demonstrated American that legislators don’t got no use for them there science-y types.
Boru
‘I can’t be having with this.’ - Esmeralda Weatherwax
